jump to navigation
jump to content
Search in Articles and Documents
generate
PDF
-Version of this page
1:
H
ome
(ALT-H)
2:
H
M
A Joint
(ALT-M)
2.1:
H
e
ads of Agencies
(ALT-E)
3:
H
u
man Medicines
(ALT-U)
4:
V
eterinary Medicines
(ALT-V)
You are here:
HMA
Joint
>
Heads of Agencies
>
HMA
Topics
> Availability of Medicines
2.1.1:
Ab
o
ut
HMA
(ALT-O)
2.1.2:
T
he Approval system
(ALT-T)
2.1.3:
HMA
To
p
ics
(ALT-P)
2.1.3.1:
HMA
W
orking Group on Product Testing
(ALT-W)
2.1.3.2:
HMA
S
trategy Paper
(ALT-S)
2.1.3.3:
J
oint
HMA
/EMA Office of Training Steering Group
(ALT-J)
2.1.3.4:
Be
n
chmarking of European Medicines Agencies
(ALT-N)
2.1.3.5:
Ava
i
lability of Medicines
(ALT-I)
2.1.3.6:
Te
l
ematics
(ALT-L)
2.1.4:
Sta
k
eholder Information
(ALT-K)
2.1.5:
HMA
C
alendar
(ALT-C)
2.1.6:
FA
Q
(ALT-Q)
2.1.7:
Contact fo
r
m
(ALT-R)
2.1.8:
Contact Points
AVAILABILITY OF MEDICINES
Report of
HMA
Management Group Task Force: availability of human medicinal products (November 2007)
Click
here
